TNF and inflammatory bowel disease: A prospective randomized controlled study enrolling 90 patients with IBD who had failed ADA/IFX treatment (CD = 48) found that combining a TNF inhibitor and azathioprine had higher rates of clinical failure-free survival and pharmacokinetic failure-free survival than TNF inhibitor alone [37].